In 2023, the total revenue of the Italian pharmaceutical group Recordati amounted to over two billion euros, most of which came from the production and marketing of specialty medicines. Rare diseases drugs were the category generating the largest revenues, with over 714 million euros, followed by the branded drug Zanidip, which generated revenue for around 145 million euros. This statistic breaks down the revenue of Italian pharmaceutical company Recordati in 2023, by product (in 1,000 euros).
Revenue of Italian pharmaceutical company Recordati in 2023, by product
(in 1,000 euros)
Characteristic
Revenue in thousand euros
Drugs for rare diseases
714,720
Zanidip
144,959
Eligard
110,682
Seloken/Seloken ZOK/Logimax
97,983
Urorec
70,038
Livazo
44,616
Zanipress
36,412
Avodart (dutasteride) and Combodart/Duodart (dutasteride/tamsulosin)
25,594
Other corporate products*
346,066
Created with Highcharts 7.2.2Revenue in thousand euros714,720714,720144,959144,959110,682110,68297,98397,98370,03870,03844,61644,61636,41236,41225,59425,594346,066346,066Drugs for rare diseasesZanidipEligardSeloken/Seloken ZOK/LogimaxUrorecLivazoZanipressAvodart (dutasteride) and Combodart/Duodart (dutasteride/tamsulosin)Other corporate products*
You have no right to use this feature.
Make sure to contact us if you are interested in scientific citation.
You can upgrade your account to enable this functionality for all statistics.
This feature is not available with your current account.Request access
Learn more about how Statista can support your business.
Recordati. (April 23, 2024). Revenue of Italian pharmaceutical company Recordati in 2023, by product (in 1,000 euros) [Graph]. In Statista. Retrieved December 29, 2024, from https://www.statista.com/statistics/816867/worldwide-ebit-of-the-italian-pharmaceutical-company-recordati-by-product/
Recordati. "Revenue of Italian pharmaceutical company Recordati in 2023, by product (in 1,000 euros)." Chart. April 23, 2024. Statista. Accessed December 29, 2024. https://www.statista.com/statistics/816867/worldwide-ebit-of-the-italian-pharmaceutical-company-recordati-by-product/
Recordati. (2024). Revenue of Italian pharmaceutical company Recordati in 2023, by product (in 1,000 euros). Statista. Statista Inc.. Accessed: December 29, 2024. https://www.statista.com/statistics/816867/worldwide-ebit-of-the-italian-pharmaceutical-company-recordati-by-product/
Recordati. "Revenue of Italian Pharmaceutical Company Recordati in 2023, by Product (in 1,000 Euros)." Statista, Statista Inc., 23 Apr 2024, https://www.statista.com/statistics/816867/worldwide-ebit-of-the-italian-pharmaceutical-company-recordati-by-product/
Recordati, Revenue of Italian pharmaceutical company Recordati in 2023, by product (in 1,000 euros) Statista, https://www.statista.com/statistics/816867/worldwide-ebit-of-the-italian-pharmaceutical-company-recordati-by-product/ (last visited December 29, 2024)
Revenue of Italian pharmaceutical company Recordati in 2023, by product (in 1,000 euros) [Graph], Recordati, April 23, 2024. [Online]. Available: https://www.statista.com/statistics/816867/worldwide-ebit-of-the-italian-pharmaceutical-company-recordati-by-product/
Profit from additional features with an Employee Account
Please create an employee account to be able to mark statistics as favorites.
Then you can access your favorite statistics via the star in the header.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.